Aurora Cannabis Inc. (ACB)
| Market Cap | 238.70M |
| Revenue (ttm) | 238.84M |
| Net Income (ttm) | 1.58M |
| Shares Out | 56.23M |
| EPS (ttm) | 0.03 |
| PE Ratio | 146.12 |
| Forward PE | 35.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 737,798 |
| Open | 4.310 |
| Previous Close | 4.260 |
| Day's Range | 4.160 - 4.310 |
| 52-Week Range | 3.422 - 7.200 |
| Beta | 3.32 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Jun 18, 2025 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Ped... [Read more]
News
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDA...
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026...
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, the...
Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters...
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona K...
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline
Aurora Cannabis (ACB) shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S.
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Canada-based medical marijuana company Aurora Cannabis Inc.'s ACB stock is trading lower after it released its fourth quarter 2025 earnings.
Aurora Cannabis Shares Fall on Polish Setback, Higher Costs in 4Q
Aurora Cannabis slid Wednesday morning after the company said regulatory headwinds in Poland hit prescription volumes and higher logistics costs pressured margins in the fiscal fourth quarter.
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday.
Aurora Cannabis 4Q Loss Narrows as Medical Cannabis Drives Revenue Beat
Aurora Cannabis's loss narrowed in its fiscal fourth quarter thanks to strong growth in its medical-cannabis business.
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA 1 of $49.7 million, representing 261% YoY...
Aurora Cannabis: Poised For Its First Profitable Year
Aurora Cannabis is on track for its first profitable year, driven by a strategic pivot to high-margin medical cannabis and disciplined cost management. Strong international medical sales, improved mar...
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB , June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc....
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information
NASDAQ | TSX: ACB EDMONTON, AB , June 3, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, anno...
June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth
As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasin...
Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Discuss Key Trends, Market Opportunities and the Future of the Global Cannabis Industry EDMONTON, AB , May 27, 2025 /PRNewswire/ - Aurora...
Aurora Cannabis: Underappreciated Turnaround
Aurora Cannabis remains a bullish opportunity due to its cheap valuation and an improving business model, despite recent stock weakness. International medical cannabis sales are growing, especially in...
3 Marijuana Stocks For The Long Term Investing
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the ...
Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility
NASDAQ | TSX: ACB Company's Long-Standing Investment in Operational Excellence Continues with Industry Leading Upgrades and Renaming the Facility to Aurora Alpine EDMONTON, AB , April 30, 2025 /PRNew...
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appet...
Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Expands Patient Offering with Innovative Dosage Solution EDMONTON, AB , April 15, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TS...
Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail
Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB , March 31, 2025 /PRNewswire/ - Auror...